These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 477025)

  • 1. Transfer factor and hepatitis B: a double blind study.
    Ellis-Pegler R; Sutherland DC; Douglas R; Woodfield DG; Wilson JD
    Clin Exp Immunol; 1979 May; 36(2):221-6. PubMed ID: 477025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial.
    Mutchnick MG; Appelman HD; Chung HT; Aragona E; Gupta TP; Cummings GD; Waggoner JG; Hoofnagle JH; Shafritz DA
    Hepatology; 1991 Sep; 14(3):409-15. PubMed ID: 1874487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic B virus hepatitis with specific transfer factor.
    Mazzella G; Ronchi M; Villanova N; Mohamed AA; Pizza G; De Vinci C; Viza D; Roda E; Barbara L
    J Exp Pathol; 1987; 3(4):421-3. PubMed ID: 3454802
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transfer factor as adjuvant immunotherapy in invasive cervix cancer. Report of a double-blind study].
    Wagner G; Gitsch E; Havelec L; Knapp W; Rainer H; Selander S
    Wien Klin Wochenschr; 1983 Oct; 95(20):738-42. PubMed ID: 6362210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
    Mobacken H; Hanson LA; Lindholm L; Ljunggren C
    Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
    Chisari FV; Routenberg JA; Edgington TS
    J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
    Collins RC; Espinoza LR; Plank CR; Ebers GC; Rosenberg RA; Zabriskie JB
    Clin Exp Immunol; 1978 Jul; 33(1):1-11. PubMed ID: 361313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bilirubinemia and blood transaminase activity in certain stages of acute viral hepatitis B].
    Ilić V; Begic-Janev A; Perisić Z; Nikolić P; Bajić-Zlatković V
    Srp Arh Celok Lek; 1982 Jan; 110(1):43-7. PubMed ID: 7157062
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of acute hepatitis B in homosexual men to chronic hepatitis B. Prospective study of placebo recipients in a hepatitis B vaccine trial.
    Shah N; Ostrow D; Altman N; Baker AL
    Arch Intern Med; 1985 May; 145(5):881-2. PubMed ID: 3158291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohepatologic and clinical monitoring of neuramide therapy in acute viral hepatitis B].
    Corridori S; Trespi G; Baldini E; Campisi D; Renzetti I; Calderon W
    Boll Ist Sieroter Milan; 1985; 64(1):42-51. PubMed ID: 3159401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
    Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
    J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor in the attempted treatment of patients with HBsAg-positive chronic liver disease.
    Jain S; Thomas HC; Sherlock S
    Clin Exp Immunol; 1977 Oct; 30(1):10-5. PubMed ID: 606432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
    Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
    J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
    Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
    Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method].
    Asada S; Ishimaru T; Kubo S; Kodama H; Masuda K
    Encephale; 1976; 2(1):73-83. PubMed ID: 770152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer factor for adjuvant immunotherapy in cervical cancer.
    Wagner G; Knapp W; Gitsch E; Selander S
    Cancer Detect Prev Suppl; 1987; 1():373-6. PubMed ID: 3319147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.